{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T23:31:23Z","timestamp":1772580683906,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T00:00:00Z","timestamp":1559692800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s10096-019-03602-2","type":"journal-article","created":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T01:10:08Z","timestamp":1559697008000},"page":"1731-1735","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Long-term durability and safety of fecal microbiota transplantation for recurrent or refractory Clostridioides difficile infection with or without antibiotic exposure"],"prefix":"10.1007","volume":"38","author":[{"given":"Christine H.","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jocelyn","family":"Chai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keely","family":"Hammond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong Ran","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yogita","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0474-6032","authenticated-orcid":false,"given":"Christiana","family":"Goldeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,5]]},"reference":[{"issue":"S2","key":"3602_CR1","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.1093\/cid\/cis335","volume":"55","author":"ER Dubberke","year":"2012","unstructured":"Dubberke ER, Olsen MA (2012) Burden of Clostridium difficile on the healthcare system. Clin Infect Dis 55(S2):S88\u2013S92. \n                    https:\/\/doi.org\/10.1093\/cid\/cis335","journal-title":"Clin Infect Dis"},{"issue":"9","key":"3602_CR2","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1056\/NEJMoa1408913","volume":"372","author":"F Lessa","year":"2015","unstructured":"Lessa F, Mu Y, Bamberg W et al (2015) Burden of Clostridium difficile infection in the United States. N Engl J Med 372(9):825\u2013834. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1408913","journal-title":"N Engl J Med"},{"key":"3602_CR3","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1056\/NEJMra0707500","volume":"359","author":"C Kelly","year":"2008","unstructured":"Kelly C, LaMont JT (2008) Clostridium difficile \u2014 more difficult than ever. N Engl J Med 359:1932\u20131940","journal-title":"N Engl J Med"},{"key":"3602_CR4","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1111\/j.1572-0241.2002.05839.x","volume":"97","author":"LV McFarland","year":"2002","unstructured":"McFarland LV, Elmer GW, Surawicz CM (2002) Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol 97:1769\u20131775. \n                    https:\/\/doi.org\/10.1016\/S0002-9270(02)04195-3","journal-title":"Am J Gastroenterol"},{"key":"3602_CR5","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1001\/jama.1994.03510480037031","volume":"271","author":"LV McFarland","year":"1994","unstructured":"McFarland LV, Surawicz CM, Greenberg RN et al (1994) A randomized placebo-controlled trial combination with standard antibiotics for Clostridium difficile disease. JAMA. 271:1913\u20131918","journal-title":"JAMA."},{"issue":"4","key":"3602_CR6","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/ajg.2013.59","volume":"108","author":"Z Kassam","year":"2013","unstructured":"Kassam Z, Lee CH, Yuan Y, Hunt RH (2013) Fecal microbiota transplantation for clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol 108(4):500\u2013508. \n                    https:\/\/doi.org\/10.1038\/ajg.2013.59","journal-title":"Am J Gastroenterol"},{"key":"3602_CR7","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/apt.13492","volume":"43","author":"Y Li","year":"2016","unstructured":"Li Y, Cai H, Wang Z, Xu J, Fang J (2016) Systematic review with meta-analysis: long-term outcomes of faecal microbiota transplantation for Clostridium difficile infection. Aliment Pharmacol Ther 43:445\u2013457. \n                    https:\/\/doi.org\/10.1111\/apt.13492","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"3602_CR8","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1007\/s10096-014-2088-9","volume":"33","author":"CH Lee","year":"2014","unstructured":"Lee CH, Belanger JE, Kassam Z et al (2014) The outcome and long-term follow-up of 94 patients with recurrent and refractory Clostridium difficile infection using single to multiple fecal microbiota transplantation via retention enema. Eur J Clin Microbiol Infect Dis 33(8):1425\u20131428. \n                    https:\/\/doi.org\/10.1007\/s10096-014-2088-9","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"10","key":"3602_CR9","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1007\/s10620-016-4229-8","volume":"61","author":"M Girotra","year":"2016","unstructured":"Girotra M, Garg S, Anand R, Song Y (2016) Fecal microbiota transplantation for recurrent Clostridium difficile infection in the elderly: long-term outcomes and microbiota changes. Dig Dis Sci 61(10):3007\u20133015. \n                    https:\/\/doi.org\/10.1007\/s10620-016-4229-8","journal-title":"Dig Dis Sci"},{"key":"3602_CR10","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/ajg.2012.60","volume":"107","author":"LJ Brandt","year":"2012","unstructured":"Brandt LJ, Aroniadis OC, Mellow M et al (2012) Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol 107:1079\u20131087. \n                    https:\/\/doi.org\/10.1038\/ajg.2012.60","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 1","key":"3602_CR11","doi-asserted-by":"publisher","first-page":"S384","DOI":"10.1093\/ofid\/ofx163.954","volume":"4","author":"Y Mamo","year":"2017","unstructured":"Mamo Y, Woodworth M, Sitchenko K, Dhere T, Kraft C (2017) Durability and long-term clinical outcomes of fecal microbiota transplant (FMT) treatment in patients with recurrent C. difficile infection. Open Forum Infect Dis 4(Suppl 1):S384\u2013S385","journal-title":"Open Forum Infect Dis"},{"key":"3602_CR12","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1016\/S0016-5085(16)30204-9","volume":"150","author":"M Fischer","year":"2016","unstructured":"Fischer M, Phelps E, Bolla R, Storm M, Allegretti JR (2016) Long-term risk of Clostridium difficile infection recurrence with or without antibiotic exposure following successful fecal microbiota transplant. Gastroenterology. 150:S23. \n                    https:\/\/doi.org\/10.1016\/S0016-5085(16)30204-9","journal-title":"Gastroenterology."},{"issue":"5","key":"3602_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MCG.0000000000000374","volume":"50","author":"OC Aroniadis","year":"2015","unstructured":"Aroniadis OC, Brandt LJ, Greenberg A et al (2015) Long-term follow-up study of fecal microbiota transplantation for severe and\/or complicated Clostridium difficile infection. J Clin Gastroenterol 50(5):1. \n                    https:\/\/doi.org\/10.1097\/MCG.0000000000000374","journal-title":"J Clin Gastroenterol"},{"key":"3602_CR14","doi-asserted-by":"publisher","first-page":"CD006095","DOI":"10.1002\/14651858.CD006095.pub4","volume":"12","author":"JZ Goldenberg","year":"2017","unstructured":"Goldenberg JZ, Yap C, Lytvyn L et al (2017) Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev 12:CD006095. \n                    https:\/\/doi.org\/10.1002\/14651858.CD006095.pub4","journal-title":"Cochrane Database Syst Rev"},{"issue":"7122","key":"3602_CR15","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/nature05414","volume":"444","author":"PJ Turnbaugh","year":"2006","unstructured":"Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 444(7122):1027\u20131031. \n                    https:\/\/doi.org\/10.1038\/nature05414","journal-title":"Nature."},{"key":"3602_CR16","doi-asserted-by":"publisher","first-page":"1241214","DOI":"10.1126\/science.1241214","volume":"341","author":"VK Ridaura","year":"2013","unstructured":"Ridaura VK, Faith JJ, Rey FE et al (2013) Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science (80- ) 341:1241214. \n                    https:\/\/doi.org\/10.1126\/science.1241214","journal-title":"Science (80- )"},{"issue":"Suppl 1","key":"3602_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ofid\/ofv004","volume":"2","author":"N Alang","year":"2015","unstructured":"Alang N, Kelly CR (2015) Weight gain after fecal microbiota transplantation. Ofid. 2(Suppl 1):1\u20138. \n                    https:\/\/doi.org\/10.1093\/ofid\/ofv004","journal-title":"Ofid."},{"issue":"8","key":"3602_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0161174","volume":"11","author":"S Wang","year":"2016","unstructured":"Wang S, Xu M, Wang W et al (2016) Systematic review: adverse events of fecal microbiota transplantation. PLoS One 11(8):1\u201324. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0161174","journal-title":"PLoS One"},{"issue":"2","key":"3602_CR19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jhin.2015.10.024","volume":"92","author":"M Baxter","year":"2016","unstructured":"Baxter M, Colville A (2016) Adverse events in faecal microbiota transplant: a review of the literature. J Hosp Infect 92(2):117\u2013127. \n                    https:\/\/doi.org\/10.1016\/j.jhin.2015.10.024","journal-title":"J Hosp Infect"},{"issue":"6","key":"3602_CR20","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1080\/19490976.2017.1353848","volume":"8","author":"T Qazi","year":"2017","unstructured":"Qazi T, Amaratunga T, Barnes EL, Fischer M, Kassam Z, Allegretti JR (2017) The risk of inflammatory bowel disease flares after fecal microbiota transplantation: systematic review and meta-analysis. Gut Microbes 8(6):574\u2013588. \n                    https:\/\/doi.org\/10.1080\/19490976.2017.1353848","journal-title":"Gut Microbes"},{"issue":"6","key":"3602_CR21","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/apt.13737","volume":"44","author":"A Wadhwa","year":"2016","unstructured":"Wadhwa A, AlNahhas M, Dierkhising R et al (2016) High risk of post-infectious irritable bowel syndrome in patients with Clostridium difficile infection. Aliment Pharmacol Ther 44(6):576\u2013582. \n                    https:\/\/doi.org\/10.1002\/nbm.3369.Three","journal-title":"Aliment Pharmacol Ther"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-019-03602-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-019-03602-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-019-03602-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T10:38:36Z","timestamp":1567075116000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-019-03602-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,5]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["3602"],"URL":"https:\/\/doi.org\/10.1007\/s10096-019-03602-2","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,5]]},"assertion":[{"value":"9 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"CL received grants from Physicians Services Incorporated, Canadian Institutes of Health Research, Rebiotix and Seres Therapeutics to conduct fecal microbiota transplant trials. JC, KH, SRJ, YP, CG, and PK have no conflicts to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Hamilton Integrated Research Ethics Board. An informed consent was obtained from eligible participants prior to distributing the questionnaire.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}